Stephane Lezmi

Dr. Stephane Lezmi

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2014 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
LTLi Tang
Li Tang
XYXujuan Yang
Xujuan Yang
QYQian Yin
Qian Yin
KCKaimin Cai
Kaimin Cai
HWHua Wang
Hua Wang
JCJianjun Cheng
Jianjun Cheng
Significance: Understanding the interdependency of physiochemical properties of nanomedicine (NM) in correlation to its biological response and function is crucial for additional development of anticancer NM. Here, we prepared monodisperse drug–silica nanoconjugates in three distinct sizes (20, 50, and 200 nm) with other physiochemical properties controlled to be identical to investigate size-dependent biodistribution, tumor tissue penetration and clearance, and anticancer efficacy in various tumor models. We also developed a mathematical model of the spatiotemporal distribution of NM within a tumor to gain insight into the size-dependent interaction with tumor. Our studies show clear evidence that there is an optimal size of anticancer NM and that NM with the optimal size has the highest tumor retention integrated over time.

13 February 2017 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
HWHua Wang
Hua Wang
RWRuibo Wang
Ruibo Wang
KCKaimin Cai
Kaimin Cai
HHHua He
Hua He
YLYang Liu
Yang Liu
JCJianjun Cheng
Jianjun Cheng

1 April 2015 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
RSRita S. Strakovsky
Rita S. Strakovsky
HWHuan Wang
Huan Wang
NENicki J. Engeseth
Nicki J. Engeseth
Jodi FlawsJodi Flaws
Jodi Flaws
WHWilliam G. Helferich
William G. Helferich
SLStephane Lezmi
Stephane Lezmi

18 May 2018 in Toxins
Verified
Journal Article
Open access
PDF file
EFElena Fonfria
Elena Fonfria
JMJacquie Maignel
Jacquie Maignel
SLStephane Lezmi
Stephane Lezmi
VMVincent Martin
Vincent Martin
ASAndrew Splevins
Andrew Splevins
JKJohannes Krupp
Johannes Krupp
Botulinum neurotoxin (BoNT) is a major therapeutic agent that is licensed in neurological indications, such as dystonia and spasticity. The BoNT family, which is produced in nature by clostridial bacteria, comprises several pharmacologically distinct proteins with distinct properties. In this review, we present an overview of the current therapeutic landscape and explore the diversity of BoNT proteins as future therapeutics. In recent years, novel indications have emerged in the fields of pain, migraine, overactive bladder, osteoarthritis, and wound healing. The study of biological effects distal to the injection site could provide future opportunities for disease-tailored BoNT therapies. However, there are some challenges in the pharmaceutical development of BoNTs, such as liquid and slow-release BoNT formulations; and, transdermal, transurothelial, and transepithelial delivery. Innovative approaches in the areas of formulation and delivery, together with highly sensitive analytical tools, will be key for the success of next generation BoNT clinical products.

7 November 2012 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
LTLi Tang
Li Tang
XYXujuan Yang
Xujuan Yang
LDLawrence W Dobrucki
Lawrence W Dobrucki
ICIsthier Chaudhury
Isthier Chaudhury
QYQian Yin
Qian Yin
JCJianjun Cheng
Jianjun Cheng

29 May 2014 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
XTXin Tang
Xin Tang
TKTheresa B Kuhlenschmidt
Theresa B Kuhlenschmidt
QLQian Li
Qian Li
SAShahjahan Ali
Shahjahan Ali
SLStephane Lezmi
Stephane Lezmi
Mark KuhlenschmidtMark Kuhlenschmidt
Mark Kuhlenschmidt
Metastasis accounts for the majority of deaths from cancer. Although tumor microenvironment has been shown to have a significant impact on the initiation and/or promotion of metastasis, the mechanism remains elusive. We previously reported that HCT-8 colon cancer cells underwent a phenotypic transition from an adhesive epithelial type (E-cell) to a rounded dissociated type (R-cell) via soft substrate culture, which resembled the initiation of metastasis. The objective of current study was to investigate the molecular and metabolic mechanisms of the E-R transition.